EUVIMEDEUVIMED entdecken
Open Access

Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53

Md Kabir, Ning Sun, Xiaoping Hu, Tiphaine C Martin, Jingjie Yi, Yue Zhong, Yan Xiong, H Ümit Kaniskan iD, Wei Gu, Ramon Parsons, Jian Jin iD

Journal of the American Chemical Society · 12.07.2023 · 145 (27) · 14932-14944

DOI: 10.1021/jacs.3c04640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 26.06.2023. Verfasst von Md Kabir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Center for Therapeutics Discovery, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53AcetylationHumansCell Line, TumorMutationModels, MolecularProtein Processing, Post-TranslationalProtein Structure, Tertiary

Substanzen

Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Mount Sinai Center for Therapeutics Discovery, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
  • Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
  • Institute for Cancer Genetics, Department of Pathology and Cell Biology, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York 10032, USA.

ORCID-Profile: H Ümit Kaniskan, Jian Jin

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS
  • National Cancer Institute
  • Icahn School of Medicine at Mount Sinai
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Kabir, M., Sun, N., Hu, X., Martin, T. C., Yi, J., Zhong, Y., Xiong, Y., Kaniskan, H. Ü., Gu, W., Parsons, R., & Jin, J. (2023). Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53. Journal of the American Chemical Society, 145(27), 14932-14944. https://doi.org/10.1021/jacs.3c04640

Vancouver

Kabir M, Sun N, Hu X, Martin TC, Yi J, Zhong Y, et al. Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53. Journal of the American Chemical Society. 2023;145(27):14932-14944. doi:10.1021/jacs.3c04640

BibTeX
@article{Kabir2023,
  author = {Kabir, Md and Sun, Ning and Hu, Xiaoping and Martin, Tiphaine C and Yi, Jingjie and Zhong, Yue and Xiong, Yan and Kaniskan, H Ümit and Gu, Wei and Parsons, Ramon and Jin, Jian},
  title = {Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53},
  journal = {Journal of the American Chemical Society},
  year = {2023},
  volume = {145},
  number = {27},
  pages = {14932--14944},
  doi = {10.1021/jacs.3c04640}
}
Kostenlos starten →